Latest filing published 12 Jun 2026 for Pacira BioSciences, Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Marcelo Bigal appears in our data through filings on Pacira BioSciences, Inc. shares, published by SEC (Form 4). Between 12 June 2024 and 10 June 2026, the trades on record add up to 7 filings.
The open-market side counts 3 purchases for €93k alongside 1 sale for €100k. On balance, insiders were net sellers of €6,638. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants.
In size, the median ticket on the buying side is €37k.
The newest entry dates from 12 June 2026: a share grant, in Pacira BioSciences, Inc. The latest purchase dates back some time: it was published 796 days ago, on 19 August 2024. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations